Cover Image

HARDBACK
$59.95



View/Hide Left Panel

REFERENCES

AIAI (Artificial Intelligence Applications Institute). 2003. TOPKAT—The Open Practical Knowledge Acquisition Toolkit. Online. University of Edinburgh. Available at http://www.aiai.ed.ac.uk/~jkk/topkat.html. Accessed July 9, 2003.

Anderson CA, Clark RL. 1990. External genitalia of the rat: Normal development and the histogenesis of 5 alpha-reductase inhibitor-induced abnormalities. Teratology 42:483–496.

Asano N, Kato A, Matsui K, Watson AA, Nash RJ, Molyneux RJ, Hackett L, Topping J, Winchester B. 1997. The effects of calystegines isolated from edible fruits and vegetables on mammalian liver glycosidases. Glycobiology 7:1085–1088.


Bayne CW, Donnelly F, Ross M, Habib FK. 1999. Serenoa repens (Permixon): A 5 alphareductase types I and II inhibitor–A new evidence in coculture model of BPH. Prostate 40:232–241.

Bowman CJ, Barlow NJ, Turner KJ, Wallace DG, Foster PMD. 2003. Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat. Toxicol Sci 74:393–406.


Clark RL, Antonello JM, Grossman SJ, Wise LD, Anderson C, Bagdon WJ, Prahalada S, MacDonald JS, Robertson RT. 1990. External genitalia abnormalities in male rats exposed in utero to finasteride, a 5 alpha-reductase inhibitor. Teratology 42:91–100.

Clark RL, Anderson CA, Prahalada S, Robertson RT, Lochry EA, Leonard YM, Stevens JL, Hoberman AM. 1993. Critical developmental periods for effects on male rat genitalia induced by finasteride, a 5 alpha-reductase inhibitor. Toxicol Appl Pharmacol 119:34–40.

Cordell GA, Quinn-Beattie ML, Farnsworth NR. 2001. The potential of alkaloids in drug discovery. Phytother Res 15:183–205.

Coulombe RA. 2003. Pyrrolizidine alkaloids in foods. In: Taylor SL, ed. Advances in Food and Nutrition Research. Vol 45. Amsterdam: Academic Press. Pp. 61–99.


Drager B, van Almsick A, Mrachtz G. 1995. Distribution of calystegines in several Solanaceae. Planta Med 61:577–579.


FDA (Food and Drug Administration). 2004. Final rule declaring dietary supplements containing ephedrine alkaloids adulterated because they present an unreasonable risk; Final rule. Fed Regis 69:6787–6854.

Fong HHS. 2002. Integration of herbal medicine into modern medical practices: Issues and prospects. Intergr Cancer Ther 1:287–293.

Furuya I, Watanabe S. 1993. Discriminative stimulus properties of ephedra herb (Ephedra sinica) in rats. Yakubutsu Seishin Kodo 13:33–38.


Harborne JB. 1993. Introduction to Ecological Biochemistry. 4th ed. London: Academic Press.

Hartmann T, Witte L. 1995. Chemistry, biology and chemoecology of pyrrolizidine alkaloids. In: Pelletier SW, ed. Alkaloids: Chemical and Biological Perspectives. Vol 9. Oxford, UK: Levier Science.


IPNI (International Plant Names Index). 2004. About Index Kewensis. Online. Available at http://www.ipni.org/ik_blurb.html. Accessed March 22, 2004.

Izzotti A, Balansky RM, Blagoeva PM, Mircheva ZI, Tulimiero L, Cartiglia C, De Flora S. 1998. DNA alterations in rat organs after chronic exposure to cigarette smoke and/or ethanol ingestion. FASEB J 12:753–758.


Kurzrock EA, Jegatheesan P, Cunha GR, Baskin LS. 2000. Urethral development in the fetal rabbit and induction of hypospadias: A model for human development. J Urol 164:1786–1792.


Lake CR, Quirk RS. 1984. CNS stimulants and the look-alike drugs. Psychiatr Clin North Am 7:689–701.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement